XRAY DENTSPLY SIRONA INC US FDA Inspections 8-K Filing 2024 - Sales Suspension DENTSPLY SIRONA Inc. is suspending the sale of its Byte Aligner System and Impression Kits due to regulatory reviews, expecting a material impact on its operations, while preliminary Q3 2024 net sales are estimated at $951 million with adjusted EPS between $0.49 and $0.51, and potential goodwill impairment charges of $450-$550 million.Get access to all SEC 8-K filings of the DENTSPLY SIRONA INC